A comprehensive analysis of gene expression profiling data in COVID-19 patients for discovery of specific and differential blood biomarker signatures

A comprehensive analysis of gene expression profiling data in COVID-19 patients for discovery of specific and differential blood biomarker signatures

Abstract COVID-19 is a newly recognized illness with a predominantly respiratory presentation. Although initial analyses have identified groups of candidate gene biomarkers for the diagnosis of COVID-19, they have yet to identify clinically applicable biomarkers, so we need disease-specific diagnost...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Maryam Momeni, Maryam Rashidifar, Farinaz Hosseini Balam, Amir Roointan, Alieh Gholaminejad
Format:	Artykuł
Język:	English
Wydane:	Nature Portfolio 2023-04-01
Seria:	Scientific Reports
Dostęp online:	https://doi.org/10.1038/s41598-023-32268-2

Podobne zapisy

Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets
od: Mohammadjavad Naghdibadi, i wsp.
Wydane: (2023-02-01)

Metabolome panels as potential noninvasive biomarkers for primary glomerulonephritis sub-types: meta-analysis of profiling metabolomics studies
od: Amir Roointan, i wsp.
Wydane: (2023-11-01)

Transcriptome meta-analysis and validation to discovery of hub genes and pathways in focal and segmental glomerulosclerosis
od: Amir Roointan, i wsp.
Wydane: (2024-09-01)

An Integrative in silico Study to Discover Key Drivers in Pathogenicity of Focal and Segmental Glomerulosclerosis
od: Alieh Gholaminejad, i wsp.
Wydane: (2022-03-01)

Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets
od: Fatemeh Hojjati, i wsp.
Wydane: (2023-09-01)

Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets
od: Fatemeh Hojjati, i wsp.
Wydane: (2023-09-01)

Maximizing biomarker discovery by minimizing gene signatures
od: Chang Chang, i wsp.
Wydane: (2011-12-01)

Biomarker Gene Signature Discovery Integrating Network Knowledge
od: Holger Fröhlich, i wsp.
Wydane: (2012-02-01)

Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers.
od: Ping Yip, i wsp.
Wydane: (2011-01-01)

Integrative multi-platform meta-analysis of hepatocellular carcinoma gene expression profiles for identifying prognostic and diagnostic biomarkers
od: Maryam Gholizadeh, i wsp.
Wydane: (2023-07-01)

Comprehensive biomarker discovery and validation for clinical application /
od: Horvatovich, Peter, i wsp.
Wydane: (2013)

Metabolomics Reveals Molecular Signatures for Psoriasis Biomarkers and Drug Targets Discovery
od: Song Q, i wsp.
Wydane: (2023-11-01)

Inhibitory effect of chrysin on estrogen biosynthesis by suppression of enzyme aromatase (CYP19): A systematic review
od: Farinaz Hosseini Balam, i wsp.
Wydane: (2020-03-01)

Healthy Eating Index-2015 and Dietary Total Antioxidant Capacity as Predictors of Prediabetes: A Case-Control Study
od: Jamal Rahmani, i wsp.
Wydane: (2021-01-01)

Comprehensive profiling of extracellular vesicles in uveitis and scleritis enables biomarker discovery and mechanism exploration
od: Lingzi Wu, i wsp.
Wydane: (2023-06-01)

Specific myeloid signatures in peripheral blood differentiate active and rare clinical phenotypes of multiple sclerosis
od: Aigli G. Vakrakou, i wsp.
Wydane: (2023-01-01)

Proteome Profiling of Diabetic Mellitus Patient Urine for Discovery of Biomarkers by Comprehensive MS-Based Proteomics
od: Yoshitoshi Hirao, i wsp.
Wydane: (2018-02-01)

Force Profile as Surgeon-Specific Signature
od: Amir Baghdadi, PhD, i wsp.
Wydane: (2023-09-01)

Modulation of Small RNA Signatures by Astrocytes on Early Neurodegeneration Stages; Implications for Biomarker Discovery
od: Leonardo López-Cepeda, i wsp.
Wydane: (2022-10-01)

MicroRNA Signature of Traumatic Brain Injury: From the Biomarker Discovery to the Point-of-Care
od: Valentina Di Pietro, i wsp.
Wydane: (2018-06-01)

Whole blood transcriptome profile identifies motor neurone disease RNA biomarker signatures
od: Sulev Kõks, i wsp.
Wydane: (2025-01-01)

Analyzing biomarker discovery: Estimating the reproducibility of biomarker sets.
od: Amir Forouzandeh, i wsp.
Wydane: (2022-01-01)

Discovery and replication of blood-based proteomic signature of PTSD in 9/11 responders
od: Monika A. Waszczuk, i wsp.
Wydane: (2023-01-01)

GENE AND METABOLITE SIGNATURES IN CHRONIC MYELOID LEUKEMIA PROGRESSION: IMPLICATIONS FOR THERAPEUTIC RESISTANCE AND BIOMARKER DISCOVERY
od: FC Almeida, i wsp.
Wydane: (2024-10-01)

Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease
od: Emmanouil Nychas, i wsp.
Wydane: (2025-01-01)

Biomarker discovery of thalassemia and sickle-cell disease from blood peptidome
od: Dong, Xueming
Wydane: (2016)

Blood biomarker discovery for autism spectrum disorder: A proteomic analysis.
od: Laura Hewitson, i wsp.
Wydane: (2024-01-01)

Biomarker discovery in galactosemia: Metabolomics with UPLC/HRMS in dried blood spots
od: Ahmad N. Alodaib, i wsp.
Wydane: (2023-04-01)

Blood biomarker discovery for autism spectrum disorder: A proteomic analysis.
od: Laura Hewitson, i wsp.
Wydane: (2021-01-01)

From the endometrium physiology to a comprehensive strategy for the discovery of ovarian cancer biomarkers
od: Janos L. Tanyi, i wsp.
Wydane: (2011-12-01)

Unveiling etiology-specific blood biomarkers in hepatocellular carcinoma: A gateway to personalized medicine: Editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma”
od: Joseph C. Ahn, i wsp.
Wydane: (2024-10-01)

Decoding the glycoproteome: a new frontier for biomarker discovery in cancer
od: Kai He, i wsp.
Wydane: (2024-03-01)

Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases
od: Mohammed Abdulhaleem, i wsp.
Wydane: (2023-11-01)

Multiplexed enrichment and genomic profiling of peripheral blood cells reveal subset-specific immune signatures
od: Vickers, Dwayne, i wsp.
Wydane: (2019)

Discovery of plasma biomarkers related to blood-brain barrier dysregulation in Alzheimer's disease
od: Dan Yuet Ruh
Wydane: (2024)

Discovery of plasma biomarkers related to blood-brain barrier dysregulation in Alzheimer’s disease
od: Yuet Ruh Dan, i wsp.
Wydane: (2024-10-01)

Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing.
od: Lawrence C LaPointe, i wsp.
Wydane: (2012-01-01)

A Metabolomics Approach and Chemometric Tools for Differentiation of Barley Cultivars and Biomarker Discovery
od: Claude Y. Hamany Djande, i wsp.
Wydane: (2021-08-01)

CNS cell-derived exosome signatures as blood-based biomarkers of neurodegenerative diseases
od: Calvin Park, i wsp.
Wydane: (2024-06-01)

Host Blood Transcriptional Signatures as Candidate Biomarkers for Predicting Progression to Active Tuberculosis
od: Chang Ho Kim, i wsp.
Wydane: (2023-04-01)